ライフサイエンスコーパス: type III secretion system

1 ets identified the mRNA for the regulator of type III secretion system.

2 ctors delivered into plant cells through the type III secretion system.

3 st events in flagellar morphogenesis and the type III secretion system.

4 tein I (SseI), a component of the Salmonella type III secretion system.

5 t Pseudomonas aeruginosa strain that lacks a type III secretion system.

6 eins on the surface of the inclusion using a Type III secretion system.

7 eploying a cohort of effector proteins via a type III secretion system.

8 rs after secretion via a dedicated flagellar Type III secretion system.

9 dation of ELT-2 requires the B. pseudomallei type III secretion system.

10 e cytoplasm and promote their export via the type III secretion system.

11 are components of the Pseudomonas aeruginosa type III secretion system.

12 ages independently of a functional bacterial type III secretion system.

13 des 57 families of effectors injected by the type III secretion system.

14 s across its vacuolar membrane via the SPI-2 type III secretion system.

15 ecreted from C. jejuni through the flagellar type III secretion system.

16 el role for YopK in controlling the Yersinia type III secretion system.

17 ocating Yops directly into host cells with a type III secretion system.

18 OmpB, Hsp60, and IncA and proteins from the type III secretion system.

19 effector, respectively, associated with the type III secretion system.

20 al effector proteins into host cells using a Type III secretion system.

21 U, an effector of the Pseudomonas aeruginosa type III secretion system.

22 mponent transport apparatus categorized as a type III secretion system.

23 are established components of the flagellar type III secretion system.

24 ol via a syringe-like organelle known as the type III secretion system.

25 ed against Yersinia and other pathogens with type III secretion systems.

26 m-negative bacteria accomplish this by using type III secretion systems.

27 a conserved component of pathogen-associated type III secretion systems.

28 ffector proteins injected into host cells by type III secretion systems.

29 quired the presence of functional Salmonella type III secretion systems.

30 e intermembrane space, as has been found for type III secretion systems.

31 regulate cell invasion-related genes of the type III secretion system 1 (T3SS-1).

32 OpaR represses the surface-sensing and type III secretion system 1 (T3SS1) regulons.

33 B, are required for activating the virulence type III secretion system 2 in response to bile salts.

34 monas fluorescens, engineered to express the type III secretion system, also reduced potato aphid and

35 which is a highly conserved component of the type III secretion system and a known virulence factor,

36 eous effectors that are secreted through the type III secretion system and a polyketide phytotoxin ca

37 ium responsible for fire blight, relies on a type III secretion system and a single injected effector

38 viral CD8(+) T-cell epitope via the Shigella type III secretion system and characterized the CD8(+) T

39 es through the activity of a plasmid-encoded type III secretion system and its associated effector pr

40 he epithem and is actively suppressed by the type III secretion system and its effector proteins.

41 is delivered into host mammalian cells via a type III secretion system and localizes to the inner sid

42 They are induced for the invasion-associated type III secretion system and possess flagella; hence, t

43 and LadS regulate genes associated with the type III secretion system and that LadS controls the exp

44 ce of needle and rod proteins from bacterial type III secretion systems and flagellin, respectively.

45 ing those encoding the lateral flagellar and type III secretion systems and N-acetylglucosamine-bindi

46 o leaves is dependent upon deployment of the type III secretion system, and the gabT triple mutant wa

47 ntain the coding capacity for a nonflagellar type III secretion system, and this mechanism has arisen

48 ellular pathogens that express flagellin and type III secretion systems, and activating mutations in

49 It senses indirectly bacterial flagellin and type III secretion systems, and responds by assembling a

50 gates that required bacterial flagella and a type III secretion system apparatus.

51 functional Salmonella pathogenicity island 1 type III secretion system appears to be required for thi

52 trate that the effectors secreted by the Ysc type III secretion system are necessary but not sufficie

53 he injectisome (iT3SS) and flagellar (fT3SS) type III secretion systems are 2 virulence factors assoc

54 Type III secretion systems are complex nanomachines used

55 Type III secretion systems are found in many Gram-negati

56 Type III secretion systems are used by many Gram-negativ

57 syringae and Xanthomonas campestris, use the type III secretion system as a molecular syringe to inje

58 e homology to ring-forming proteins found in type III secretion systems, assembles into an oligomeric

59 of the genes encoding the components of the type III secretion system borne on the locus of enterocy

60 at the introduction of a functional Shigella type III secretion system, but none of its effectors, in

61 sponses against components of the Salmonella type III secretion system can contribute to protection a

62 the Salmonella enterica serovar Typhimurium type III secretion system chaperone, FlgN, which is requ

63 's immune response, Y. enterocolitica uses a type III secretion system consisting of an injectisome a

64 -silenced plants are more susceptible to the type III secretion system-deficient bacterial strain Pse

65 Bacterial Type III Secretion Systems deliver effectors into host c

66 The Pseudomonas aeruginosa type III secretion system delivers effector proteins dir

67 Effectors produced by the type III secretion system disrupt mammalian cell membran

68 llin or the inner rod component of bacterial type III secretion systems (e.g., Salmonella PrgJ).

69 fication of two homologous Shigella flexneri type III secretion system effector E3 ligases IpaH1.4 an

70 Exoenzyme Y (ExoY) is a type III secretion system effector found in 90% of the P

71 Exotoxin Y (ExoY) is a type III secretion system effector found in ~ 90% of the

72 tium strains bearing deletions in individual type III secretion system effector genes to determine wh

73 A type III secretion system effector known as YopJ in Y. p

74 NleB, a highly conserved type III secretion system effector of A/E pathogens, sup

75 ere we found that the expression of a single type III secretion system effector protein from broad-ho

76 The type III secretion system effector protein NleE from ent

77 ed cells, both of which are dependent on the type III secretion system effector Tir.

78 ophages induced by Y. pestis, dependent upon type III secretion system effector Yersinia outer protei

79 rculosis inhibits TRIF signaling through the type III secretion system effector YopJ.

80 In the past decade, a number of type-III secretion system effector (T3Es) proteins from

81 Here we report that the EPEC type-III secretion system effector EspJ inhibits autopho

82 merase chain reaction for genes encoding the type III secretion system effectors (ExoU, ExoS, and Pcr

83 Y. pestis type III secretion system effectors YopJ and YopM can in

84 on a whole-genome phylogeny and analysis of type III secretion system effectors, the AEEC are divide

85 AEEC) are characterized by the presence of a type III secretion system encoded by the locus of entero

86 mbrella term given to E. coli that possess a type III secretion system encoded in the locus of entero

87 leum, a virulence process carried out by the type III secretion system encoded within Salmonella path

88 A-SsrB two-component regulatory system and a type III secretion system encoded within SPI-2.

89 roquinolone resistance and gene encoding the type III secretion system ExoU effector in P. aeruginosa

90 hat fluoroquinolone-resistant phenotype in a type III secretion system exoU strain background contrib

91 It uses a type III secretion system for the injection of toxins di

92 depends on effector proteins secreted by its type III secretion system for the pathogenesis of plants

93 Here, we describe a mechanism by which a type III secretion system from the bacterial enteropatho

94 Second, AphA and LuxR repress type III secretion system genes but at different times a

95 distinctive properties include homologues of type III secretion system genes in 96F, homologues of V.

96 hermore, we showed that ToxRS also regulates type III secretion system genes in chromosome I via the

97 Expression of type III secretion system genes was also found to be upr

98 Additionally, the flagellar type III secretion system has been reported to secrete p

99 h affinity binding was also observed for the type III secretion system homolog HrcN and the type VI A

100 e provide evidence that S. flexneri, via its type III secretion system, impairs the migration pattern

101 he engineering of the Salmonella Typhimurium type III secretion system in achromosomal, non-replicati

102 OspZ is an effector protein of the type III secretion system in Shigella spp. that downregu

103 the structural scaffolds for the assembly of type III secretion systems in gram-negative bacteria.

104 pathogens deliver effector proteins via the type III secretion system into infected host cells.

105 ding the delivery of virulence factors via a type III secretion system into the infected cell.

106 Type III secretion system is a key bacterial symbiosis a

107 The type III secretion system is a widespread apparatus used

108 The type III secretion system is an important Pseudomonas ae

109 Transcription of the Pseudomonas aeruginosa type III secretion system is controlled by ExsA, a membe

110 The type III secretion system is employed by many pathogens,

111 We found that the bacterial SPI-2 type III secretion system is required for ROS evasion st

112 inant, the Salmonella pathogenicity island 2 type III secretion system, is required for bacterial rep

113 pv. tomato but not when co-inoculated with a type III secretion system mutant of this pathogen.

114 nt in a virulence plasmid-cured strain and a type-III secretion system mutant.

115 tomic structure of the building block of the type III secretion system needle.

116 embly, determined to be right-handed for the type III secretion system needle.Additionally, the axial

117 R distance constraints, the structure of the type-III secretion system needle of Shigella flexneri is

118 The EspF protein is secreted by the type III secretion system of enteropathogenic and entero

119 totoxin translocated into host cells via the type III secretion system of Pseudomonas aeruginosa, is

120 holipase A2 effector protein secreted by the type III secretion system of Pseudomonas aeruginosa.

121 tance in such infection, the proteins of the Type III secretion system of Salmonella pathogenicity is

122 the latter being dependent upon a functional type III secretion system of the bacteria and the NLRC4

123 Application of the method to analysis of the type III secretion system of the human pathogen Yersinia

124 ed directly into mammalian cells through the type III secretion system of the opportunistic pathogen,

125 We further reveal type III secretion systems of environmental chlamydiae a

126 or DeltapscJ mutants that cannot assemble a type III secretion system, or with mutants lacking the t

127 s P aeruginosa adaptation, expression of the type III secretion system, proteases, and P aeruginosa b

128 YscU is a Yersinia pseudotuberculosis type III secretion system protein crucial for bacterial

129 The type III secretion system protein EspD is a critical fac

130 In a survey of type III secretion system protein production by an assor

131 sequence and structural homology to EscJ, a type III secretion system protein that forms a 24-fold s

132 Shigella type III secretion system proteins IpaB and IpaD, which

133 Type III secretion systems rely on hydrophobic transloca

134 um) pathogenicity island 1 (SPI-1) encodes a type III secretion system required for invasion of host

135 n five operons, LEE1 to LEE5, which encode a type III secretion system, several effectors, chaperones

136 tein 10 (CFP-10) antigens via the Salmonella type III secretion system (SopE amino-terminal region re

137 ncreased the production and secretion of the type III secretion system-specific translocation apparat

138 epends in part on its pathogenicity island 2 type III secretion system (SPI-2 T3SS), which is require

139 fection, Salmonella switches from assembling type III secretion system structural components to secre

140 The conserved Bsa type III secretion system (T3SS(Bsa)) is dispensable for

141 cell invasion of S. Paratyphi A occurs in a type III secretion system (T3SS) 1-independent manner an

142 onal activator of the Pseudomonas aeruginosa type III secretion system (T3SS) and a member of the Ara

143 inflammasome upon sensing components of the type III secretion system (T3SS) and flagellar apparatus

144 ne and expression dose of the antiphagocytic type III secretion system (T3SS) and induces functions c

145 Bacterial type III secretion system (T3SS) chaperones pilot substr

146 stic Gram-negative pathogen that possesses a type III secretion system (T3SS) critical for evading in

147 opathogenic Escherichia coli (EPEC) uses the type III secretion system (T3SS) effector EspL to degrad

148 We and others have demonstrated that the type III secretion system (T3SS) effector protein ExoT p

149 . Typhimurium pathogenicity island-1 (SPI-1) type III secretion system (T3SS) effectors and transloca

150 or cytotoxic to host cells, depending on the type III secretion system (T3SS) effectors encoded.

151 of Escherichia coli O157:H7 (O157) encodes a type III secretion system (T3SS) for secreting LEE-encod

152 Burkholderia pseudomallei possesses multiple type III secretion system (T3SS) gene clusters.

153 ExsA activates type III secretion system (T3SS) gene expression in Pseu

154 t system RhpRS to regulate the expression of type III secretion system (T3SS) genes and bacterial vir

155 Genes encoding the virulence-promoting type III secretion system (T3SS) in phytopathogenic bact

156 Nt138)-lcrV) and could be secreted through a type III secretion system (T3SS) in vitro and in vivo.

157 e acylhydrazides, developed as inhibitors of type III secretion system (T3SS) in Yersinia spp., have

158 Injection of effector proteins by a type III secretion system (T3SS) is a common infection s

159 The Yop-Ysc type III secretion system (T3SS) is a critical virulence

160 The Yersinia type III secretion system (T3SS) is environmentally resp

161 The type III secretion system (T3SS) is essential in the pat

162 The type III secretion system (T3SS) is essential in the pat

163 The type III secretion system (T3SS) is the most important v

164 revealed that expression of the E. ictaluri type III secretion system (T3SS) is upregulated by acidi

165 P. aeruginosa expresses a type III secretion system (T3SS) needle complex that ind

166 The type III secretion system (T3SS) of E. tarda has been id

167 The SPI-2 type III secretion system (T3SS) of intracellular Salmon

168 e receptors sense host-cell targeting by the type III secretion system (T3SS) of pathogenic Yersinia.

169 dictate export efficiency from the flagellar type III secretion system (T3SS) of Yersinia enterocolit

170 ential component of the plasmid pCD1-encoded type III secretion system (T3SS) of Yersinia pestis.

171 tic resistance regulator NfxB and the master type III secretion system (T3SS) regulator ExsA.

172 ne of its most potent virulence factors is a type III secretion system (T3SS) that injects toxins dir

173 olitica strains have a chromosomally encoded type III secretion system (T3SS) that is expressed and f

174 teropathogenic Escherichia coli (EPEC) use a type III secretion system (T3SS) to alter host ion trans

175 ny pathogenic Gram-negative bacteria use the type III secretion system (T3SS) to deliver effector pro

176 tive pathogens infect eukaryotes and use the type III secretion system (T3SS) to deliver effector pro

177 Yersinia pseudotuberculosis uses a type III secretion system (T3SS) to deliver effectors in

178 m-negative bacterial pathogens, requires its type III secretion system (T3SS) to facilitate acute inf

179 Citrobacter rodentium uses a type III secretion system (T3SS) to induce colonic crypt

180 estis, the causative agent of plague, uses a type III secretion system (T3SS) to inject cytotoxic Yop

181 syringae pv syringae B728a (PsyB728a) uses a type III secretion system (T3SS) to inject effector prot

182 Many bacteria use a type III secretion system (T3SS) to inject effector prot

183 gative pathogens, Shigella rely on a complex type III secretion system (T3SS) to inject effector prot

184 se pathogen Citrobacter rodentium, utilize a type III secretion system (T3SS) to inject multiple effe

185 hogens of animals and plants use a conserved type III secretion system (T3SS) to inject virulence eff

186 hogenic Escherichia coli uses a syringe-like type III secretion system (T3SS) to inject virulence or

187 onella and other pathogenic bacteria use the type III secretion system (T3SS) to inject virulence pro

188 diseases and mortality worldwide require the type III secretion system (T3SS) to inject virulence pro

189 s, the causative agent of plague, utilizes a type III secretion system (T3SS) to intoxicate host cell

190 hogenic Gram-negative bacteria that employ a type III secretion system (T3SS) to overcome host defens

191 Shigella flexneri uses its type III secretion system (T3SS) to promote invasion of

192 This pathogen utilizes the type III secretion system (T3SS) to suppress host defens

193 EHEC employs a type III secretion system (T3SS) to translocate 50 effec

194 Many Gram-negative bacteria utilize a type III secretion system (T3SS) to translocate virulenc

195 The Yersinia type III secretion system (T3SS) translocates Yop effect

196 s that function to regulate the secretion of type III secretion system (T3SS) translocator and effect

197 dosomal membrane damage by components of the type III secretion system (T3SS) translocon.

198 , we hypothesized that the B. bronchiseptica type III secretion system (T3SS) would be required for m

199 Bacterial entry and replication require a type III secretion system (T3SS), a widely conserved nan

200 rV is an essential part of the P. aeruginosa type III secretion system (T3SS), and its oligomeric nat

201 and regulatory components of the P. syringae type III secretion system (T3SS), essential for coloniza

202 tor proteins into the host cytosol through a type III secretion system (T3SS), leading to pronounced

203 e of disulfide bonding within the chlamydial type III secretion system (T3SS), since activity of this

204 gens assemble a needle-like nanomachine, the type III secretion system (T3SS), to inject virulence pr

205 m-negative bacteria secrete proteins using a type III secretion system (T3SS), which functions as a n

206 uberculosis requires the plasmid-encoded Ysc type III secretion system (T3SS), which functions to tra

207 cts effector proteins into plant cells via a type III secretion system (T3SS), which is required for

208 Here, we have developed a bacterial type III secretion system (T3SS)-based protein delivery

209 Here, we show that, in addition to the type III secretion system (T3SS)-dependent effector (T3S

210 e characterize a regulatory node involving a type III secretion system (T3SS)-exported protein, BtrA,

211 y virulence strategy of A/E pathogens is the type III secretion system (T3SS)-mediated delivery of ef

212 EPEC pathogenesis occurs through type III secretion system (T3SS)-mediated injection of e

213 on extrachromosomal elements in V. cholerae, type III secretion system (T3SS)-positive strains, such

214 route, and its virulence is dependent upon a type III secretion system (T3SS).

215 for expression of the Pseudomonas aeruginosa type III secretion system (T3SS).

216 tion of effectors into mammalian cells via a type III secretion system (T3SS).

217 virulence effectors into host cytosol with a type III secretion system (T3SS).

218 ne of these protein-delivery machines is the type III secretion system (T3SS).

219 uction, biofilm formation, motility, and the type III secretion system (T3SS).

220 ral important virulence factors, including a type III secretion system (T3SS).

221 lence proteins into host cells utilizing the type III secretion system (T3SS).

222 roteins translocated into the host cell by a type III secretion system (T3SS).

223 n (cholera toxin [CT]) and instead encodes a type III secretion system (T3SS).

224 he Salmonella pathogenicity island 2 (SPI-2) type III secretion system (T3SS).

225 for expression of the Pseudomonas aeruginosa type III secretion system (T3SS).

226 molecules into the host cell cytoplasm via a type III secretion system (T3SS).

227 ence effectors into the cell cytoplasm via a type III secretion system (T3SS).

228 d P. aeruginosa virulence determinant is the type III secretion system (T3SS); the production of T3SS

229 The type III secretion systems (T3SS) and secreted effectors

230 Type III Secretion Systems (T3SS) are complex bacterial

231 Flagellar type III secretion systems (T3SS) contain an essential c

232 All type III secretion systems (T3SS) harbor a member of the

233 e double membrane of Gram-negative bacteria, type III secretion systems (T3SS) occur in two evolution

234 monella virulence is largely mediated by two type III secretion systems (T3SS) that deliver effector

235 Gram-negative bacteria use type III secretion systems (T3SS) to deliver virulence f

236 enic Gram-negative bacteria use syringe-like type III secretion systems (T3SS) to inject effector pro

237 Type III secretion systems (T3SS) use a flagellum-like t

238 ing a type II secretion system (T2SS), three type III secretion systems (T3SS), and six type VI secre

239 proteins translocated into the host cell by type III secretion systems (T3SS).

240 lish infection within their hosts, including type III secretion systems (T3SS).

241 The type-III secretion system (T3SS) enables gram-negative b

242 f potential virulence factors (tdh, trh, and type III secretion system [T3SS] genes).

243 d transcription of one of the organism's two type III secretion systems (T3SS1 but not T3SS2) and hei

244 is organism requires a horizontally acquired type III secretion system (T3SS2) to infect the small in

245 ization of virulence factors--e.g. a crucial Type III secretion system (T3SS2)--rather than genome-wi

246 ted enteritis worldwide, is dependent upon a type III secretion system, T3SS2.

247 Type III secretion systems (T3SSs) are complex nanomachi

248 Type III secretion systems (T3SSs) are essential devices

249 Type III secretion systems (T3SSs) are protein injection

250 Type III Secretion Systems (T3SSs) are structurally cons

251 Type III secretion systems (T3SSs) are used by Gram-nega

252 Bacterial type III secretion systems (T3SSs) deliver proteins call

253 f Salmonella to cause disease depends on two type III secretion systems (T3SSs) encoded in two distin

254 Many Gram-negative bacterial pathogens use type III secretion systems (T3SSs) for virulence.

255 Type III secretion systems (T3SSs) inject bacterial effe

256 Type III secretion systems (T3SSs) of bacterial pathogen

257 ny pathogenic Gram-negative bacteria utilize type III secretion systems (T3SSs) to alter the normal f

258 A number of Gram-negative pathogens utilize type III secretion systems (T3SSs) to inject bacterial e

259 Salmonella species utilize type III secretion systems (T3SSs) to translocate effect

260 The assembly of type III secretion systems (T3SSs), which inject bacteri

261 pendent of all three Salmonella gene-encoded type III secretion systems (T3SSs)-Salmonella pathogenic

262 activate caspase-1 in response to bacterial type III secretion systems (T3SSs).

263 inject effector proteins into host cells via type III secretion systems (T3SSs).

264 od- and waterborne pathogen that encodes two type III secretion systems (T3SSs).

265 e inner rod and needle proteins of bacterial type III secretion systems (T3SSs).

266 Vibrio parahaemolyticus harbors two type III secretion systems (T3SSs; T3SS1 and T3SS2), of

267 biosynthesis is underpinned by a specialized type III secretion system that allows export of proteins

268 cement (LEE) genomic island, which encodes a type III secretion system that is essential to virulence

269 species is associated with a plasmid-encoded type III secretion system that translocates a set of Yop

270 lla-containing vacuole (SCV), and depends on type III secretion systems that deliver bacterial effect

271 g intracellular virulence, including the Ysa type III secretion system, the Yts2 type II secretion sy

272 ny Gram-negative bacterial pathogens use the type III secretion system to deliver effector proteins i

273 Shigella uses a type III secretion system to deliver effector proteins t

274 er Gram-negative bacterial pathogens, uses a type III secretion system to deliver multiple proteins,

275 ered Salmonella-based vector that exploits a type III secretion system to deliver selected TAA in the

276 teins, including SifA, through a specialized type III secretion system to hijack the host endosomal s

277 the Salmonella pathogenicity island 1 (SPI1) type III secretion system to induce inflammatory diarrhe

278 domonas syringae secretes effectors from its type III secretion system to infect plants.

279 S. flexneri uses a type III secretion system to inject effector proteins in

280 It deploys a type III secretion system to inject effector proteins in

281 Pseudomonas aeruginosa uses a type III secretion system to inject protein effectors in

282 hogens use a syringe-like apparatus called a type III secretion system to inject virulence factors in

283 These pathogens use a type III secretion system to inject virulence proteins (

284 effectors into host cells via a prototypical type III secretion system to promote pathogenesis.

285 ative opportunistic pathogen that utilizes a type III secretion system to subvert host innate immunit

286 Pathogenic Yersinia species utilize a type III secretion system to translocate Yop effectors i

287 merous Gram-negative bacterial pathogens use type III secretion systems to deliver effector molecules

288 sponse, attaching and effacing pathogens use type III secretion systems to introduce effectors target

289 ence factors, including adhesins, toxins and type III secretion systems, to cause both cytotoxicity i

290 ructure has been solved in complex with both type III secretion systems translocators, revealing that

291 The characterization of the major type III secretion system translocon component in both m

292 In many Gram-negative bacteria, the type III secretion system transports effector proteins i

293 The type III secretion system (TTSS) is a major virulence de

294 B is the most potent known inhibitor of the type III secretion system (TTSS) of Gram-negative bacter

295 All Shigella spp. utilize a type III secretion system (TTSS) to initiate infection.

296 several proteins that are components of the type III secretion system (TTSS).

297 rangements, while expression of a functional type III secretion system was not essential.

298 athogenic Yersinia species share a conserved type III secretion system, which delivers cytotoxic effe

299 SPI-2 encodes a type III secretion system, which functions as a nanomach

300 secretion system; in turn, it repressed the type III secretion system, which is a hallmark of chroni